Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of a Resveratrol-Based Mouthwash for Anti-Plaque Effect
NCT07393802Phase 3Not yet recruiting
- Sponsor
- University of Baghdad
- Start
- Mar 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Oroxil in dental plaque, sponsored by University of Baghdad. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Oroxil
03
Conditions
dental plaque
Beyond the preview
Go deeper on NCT07393802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393802.